Stocktwits on MSN
Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic
The authority said it has received 43 claims from patients who believe they developed the condition known as NAION after ...
Four patients in Denmark, who experienced vision loss after using Novo Nordisk's popular weight-loss and diabetes drugs ...
In an important step toward visual prostheses, biocompatible electrodes can convert infrared light into nerve impulses, as ...
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA ...
A Prescription Drug User Fee Act target date of February 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...
The submission was based on the safety and efficacy data from the phase 3 (RHODOS) and phase 4 (LEROS) studies. The US Food and Drug Administration (FDA) has granted Priority Review to Chiesi Global ...
FDA grants Priority Review to idebenone for Leber Hereditary Optic Neuropathy (LHON), a disease for which there are no existing approved treatments in the U.S.; action date of February 28, 2026 PARMA, ...
A new treatment for a debilitating genetic disease causing sudden sight loss is now available on the NHS in England. Evidence suggests that the drug, idebenone, may improve eyesight and boost the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback